About

Apixaban is a highly selective, reversible, and direct inhibitor of factor Xa, a crucial enzyme in the coagulation cascade. Its mechanism of action involves inhibiting both free and clot-bound factor Xa, as well as prothrombinase activity. Factor Xa plays a pivotal role in converting prothrombin to thrombin, which is essential for fibrin formation and subsequent blood clot development. By directly inhibiting factor Xa, apixaban effectively reduces thrombin generation and, consequently, thrombus formation, thereby preventing and treating various thromboembolic conditions. This targeted action provides effective anticoagulation with a predictable pharmacokinetic and pharmacodynamic profile, reducing the need for routine coagulation monitoring. Its favorable safety profile, particularly regarding bleeding risk compared to traditional anticoagulants, makes it a valuable therapeutic option for patients requiring antithrombotic therapy.

Uses

Prevention of stroke in non-valvular atrial fibrillation (NVAF)
Treatment of deep vein thrombosis (DVT)
Treatment of pulmonary embolism (PE)
Prophylaxis of DVT after hip or knee replacement surgery

Directions For Use

Take orally twice daily with or without food, as directed by your physician.

Benefits

Reduces risk of stroke in NVAF
Treats and prevents DVT/PE
No routine coagulation monitoring required
Lower bleeding risk compared to warfarin
Predictable pharmacokinetics
Oral administration

Side Effects

Bleeding (e.g., epistaxis, gastrointestinal, hematuria)
Nausea
Anemia
Rash
Hypersensitivity reactions
Bruising
Minor hemorrhage
Gingival bleeding
Hematuria
Post-procedural hemorrhage
Thrombocytopenia (rare)
Elevated liver enzymes (rare)

Safety Measures

Alcohol - Limit alcohol intake as it can increase the risk of bleeding.
Pregnancy - Not recommended; use only if potential benefit outweighs risk.
Breastfeeding - Not recommended; discontinue breastfeeding due to potential harm to the infant.
Liver - Contraindicated in patients with severe hepatic impairment or liver disease associated with coagulopathy.
Kidney - Use with caution in severe renal impairment; dose adjustment may be necessary.
Lung - No specific precautions for lung conditions, but monitor for signs of pulmonary hemorrhage.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.

Shipping & Location